These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7285488)

  • 1. Diethylcarbamazine disposition in patients with onchocerciasis.
    Edwards G; Awadzi K; Breckenridge AM; Gilles HM; Orme ML; Ward SA
    Clin Pharmacol Ther; 1981 Oct; 30(4):551-7. PubMed ID: 7285488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of moderate urine alkalinisation on low dose diethylcarbamazine therapy in patients with onchocerciasis.
    Awadzi K; Adjepon-Yamoah KK; Edwards G; Orme ML; Breckenridge AM; Gilles HM
    Br J Clin Pharmacol; 1986 Jun; 21(6):669-76. PubMed ID: 3017392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy of onchocerciasis with high doses of diethylcarbamazine or a single dose of ivermectin: microfilaria levels and side effects.
    Albiez EJ; Newland HS; White AT; Kaiser A; Greene BM; Taylor HR; Büttner DW
    Trop Med Parasitol; 1988 Mar; 39(1):19-24. PubMed ID: 3291074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind comparison of the efficacy and safety of ivermectin and diethylcarbamazine in a placebo controlled study of Senegalese patients with onchocerciasis.
    Diallo S; Aziz MA; Lariviere M; Diallo JS; Diop-Mar I; N'Dir O; Badiane S; Py D; Schulz-Key H; Gaxotte P
    Trans R Soc Trop Med Hyg; 1986; 80(6):927-34. PubMed ID: 3299905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of flubendazole and diethylcarbamazine in treatment of onchocerciasis.
    Dominguez-Vazquez A; Taylor HR; Greene BM; Ruvalcaba-Macias AM; Rivas-Alcala AR; Murphy RP; Beltran-Hernandez F
    Lancet; 1983 Jan; 1(8317):139-43. PubMed ID: 6130195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of variations in urinary pH on the pharmacokinetics of diethylcarbamazine.
    Edwards G; Breckenridge AM; Adjepon-Yamoah KK; Orme ML; Ward SA
    Br J Clin Pharmacol; 1981 Dec; 12(6):807-12. PubMed ID: 7340883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chemotherapy of onchocerciasis iii. A comparative study of diethylcarbamazide (DEC) and metrifonate.
    Awadzi K; Gilles HM
    Ann Trop Med Parasitol; 1980 Apr; 74(2):199-210. PubMed ID: 7002074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and laboratory changes consequent to diethylcarbamazine in patients with onchocerciasis.
    Fazen LE; Anderson RI; Fazen LE; Marroquin HF
    Am J Trop Med Hyg; 1976 Mar; 25(2):250-6. PubMed ID: 1259086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An onchocercal nodule appearing during diethylcarbamazine therapy.
    Boye ES; Connor DH
    Am J Trop Med Hyg; 1982 Nov; 31(6):1123-7. PubMed ID: 7149099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in natural killer cell activity during diethylcarbamazine treatment of patients with filariasis.
    Pedersen BK; Bygbjerg IC; Svenson M
    Acta Trop; 1987 Sep; 44(3):353-5. PubMed ID: 2892372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy of onchocerciasis: a controlled comparison of mebendazole, levamisole, and diethylcarbamazine.
    Rivas-Alcalá AR; Greene BM; Taylor HR; Domíguez-Vázquez A; Ruvalcaba-Macías AM; Lugo-Pfeiffer C; Mackenzie CD; Beltrán F
    Lancet; 1981 Sep; 2(8245):485-90. PubMed ID: 6115246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chemotherapy of onchocerciasis. XII. The prediction of microfilarial loads in patients with onchocerciasis after treatment with diethylcarbamazine in northern Ghana.
    Fulford AJ; Macfarlane SB; Awadzi K; Bell DR; Gilles HM
    Ann Trop Med Parasitol; 1987 Dec; 81(6):701-11. PubMed ID: 3503647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of renal disease on the pharmacokinetics of diethylcarbamazine in man.
    Adjepon-Yamoah KK; Edwards G; Breckenridge AM; Orme ML; Ward SA
    Br J Clin Pharmacol; 1982 Jun; 13(6):829-34. PubMed ID: 7093114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy of onchocerciasis: a controlled clinical trial of topical diethylcarbamazine (DEC) in Guatemala.
    Taylor HR; Langham ME; de Stahl EM; Figueroa LN; Beltranena F
    Tropenmed Parasitol; 1980 Sep; 31(3):357-64. PubMed ID: 7003855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in visual function and in the posterior segment of the eye during treatment of onchocerciasis with diethylcarbamazine citrate.
    Bird AC; el-Sheikh H; Anderson J; Fuglsang H
    Br J Ophthalmol; 1980 Mar; 64(3):191-200. PubMed ID: 7387952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Senegalese experience with the efficacy of ivermectin (MK 933) in the treatment of human onchocerciasis (double-blind comparative study with diethylcarbamazine citrate) (DEC.C)].
    Diop Mar I; Diallo S; Diallo JS; Ndir O; Badiane S
    Bull Acad Natl Med; 1986 Jan; 170(1):149-55. PubMed ID: 3527347
    [No Abstract]   [Full Text] [Related]  

  • 17. Topical diethylcarbamazine in the treatment of ocular onchocerciasis.
    Lazar M; Lieberman TW; Leopold IH
    Am J Trop Med Hyg; 1970 Mar; 19(2):232-3. PubMed ID: 5443071
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma level of diethylcarbamazine in jirds and hamsters.
    Kimura E; Aoki Y; Nakajima Y; Niwa M
    Southeast Asian J Trop Med Public Health; 1984 Mar; 15(1):74-9. PubMed ID: 6740383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Onchocerca volvulus micro- and macrofilarial responses in onchocerciasis patients to increased dosage of diethylcarbamazine.
    Langham ME; Beltranena F
    Trop Med Parasitol; 1985 Sep; 36(3):175-9. PubMed ID: 4081549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular changes with oral and transepidermal diethylcarbamazine therapy of onchocerciasis.
    Taylor HR; Greene BM
    Br J Ophthalmol; 1981 Jul; 65(7):494-502. PubMed ID: 7020746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.